Hartlage-Rübsamen, M.; Bluhm, A.; Piechotta, A.; Linnert, M.; Rahfeld, J.-U.; Demuth, H.-U.; Lues, I.; Kuhn, P.-H.; Lichtenthaler, S.F.; Roßner, S.;
et al. Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. Molecules 2018, 23, 924.
https://doi.org/10.3390/molecules23040924
AMA Style
Hartlage-Rübsamen M, Bluhm A, Piechotta A, Linnert M, Rahfeld J-U, Demuth H-U, Lues I, Kuhn P-H, Lichtenthaler SF, Roßner S,
et al. Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. Molecules. 2018; 23(4):924.
https://doi.org/10.3390/molecules23040924
Chicago/Turabian Style
Hartlage-Rübsamen, Maike, Alexandra Bluhm, Anke Piechotta, Miriam Linnert, Jens-Ulrich Rahfeld, Hans-Ulrich Demuth, Inge Lues, Peer-Hendrik Kuhn, Stefan F. Lichtenthaler, Steffen Roßner,
and et al. 2018. "Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation" Molecules 23, no. 4: 924.
https://doi.org/10.3390/molecules23040924
APA Style
Hartlage-Rübsamen, M., Bluhm, A., Piechotta, A., Linnert, M., Rahfeld, J.-U., Demuth, H.-U., Lues, I., Kuhn, P.-H., Lichtenthaler, S. F., Roßner, S., & Höfling, C.
(2018). Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. Molecules, 23(4), 924.
https://doi.org/10.3390/molecules23040924